Jones Day's San Diego Office serves clients in the California region and globally in a range of industries, including pharmaceuticals, biotechnology, medical devices, renewable energy, telecommunications, software, and information technology.
- Our lawyers litigate patent and trade secret disputes; negotiate joint venture, strategic alliance, licensing, and other technology-based transactions; and perform patent due diligence for potential acquirers and investors, such as venture capital firms and life science companies.
- Together with our other four offices in California, we provide all of the corporate legal services that an established public or private company or entrepreneur, emerging company, angel fund, venture capital fund, or other acquirer, investor, or seller may need, and we represent local, national, and international funds and companies in a variety of M&A, venture, and other corporate transactions.
- Clients benefit from our litigators' extensive experience in areas including commercial litigation, product liability and mass tort defense, class actions, labor and employment law, and government civil and criminal investigations, including white collar defense, qui tam, and whistleblower litigation.
- The San Diego Office is committed to pro bono services through Casa Cornelia, SDVLP, and SDCBA, and we support a number of San Diego civic, cultural, and nonprofit organizations, including CONNECT, Biocom, Future First USA, and Rady's Children's Hospital Auxiliary.
Cooper Tire & Rubber sold to The Goodyear Tire & Rubber Company for approximately $2.5 billion enterprise value
Bally's Corporation acquires Tropicana Evansville casino in series of transactions valued at $624 million in the aggregate
EagleTree Capital to sell Airtech Group, US Valve Corporation, and related entities to IDEX Corporation for $470 million
Skyworks Solutions to acquire Infrastructure and Automotive business of Silicon Laboratories for $2.75 billion
Litigation and Regulatory Considerations and Risks for Financial Market Participants in a Post-Pandemic Society